Senior Director, Business Development @ (October 2017 - December 2019)
Director Business Development @ (December 2012 - October 2017)
Director Business Development @ Zalicus, Inc. (f.k.a. CombinatoRx) (July 2010 - December 2012)
Associate Director Business Development @ (June 2009 - June 2010)
Senior Manager Business Development @ (February 2007 - February 2009)
Manager New Product Planning @ (September 2004 - February 2007)
Manager, Sales and Marketing - Decision Support @ (October 2002 - September 2004)
Intern Business Development @ (June 2001 - September 2001)
Senior Analyst @ (June 1997 - July 2000)
Research Associate @ Beth Israel Deacones Medical Center / Harvard Institutes of Medicine (January 1995 - June 1997)
Research Associate @ Seragen, Inc. (October 1993 - January 1995)
Colin Moran Education
Boston College Carroll School of Management
MBA (Finance)
University of Colorado Boulder
BA (Molecular Biology)
Colin Moran Skills
Biopharmaceuticals
Biotechnology
Business Development
Business Strategy
Clinical Development
Clinical Trials
Commercialization
Competitive Analysis
Cross-functional Team Leadership
Drug Development
Drug Discovery
Financial Analysis
Financial Modeling
Forecasting
Immunology
Leadership
Lifesciences
Market Research
Negotiation
Oncology
Pharmaceutical Industry
Product Launch
Strategic Alliances
Strategic Planning
Strategy
Microsoft Word
Cross Functional Team Leadership
Analysis
Colin Moran Summary
Colin Moran, based in Boston, MA, US, is currently a Senior Director, Transactions at Johnson & Johnson. Colin Moran brings experience from previous roles at CureVac AG, Momenta Pharmaceuticals, Inc., Zalicus, Inc. (f.k.a. CombinatoRx) and ImmunoGen, Inc.. Colin Moran holds a MBA in Finance @ Boston College Carroll School of Management. With a robust skill set that includes Biopharmaceuticals, Biotechnology, Business Development, Business Strategy, Clinical Development and more. Colin Moran has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Colin Moran?
Find contact details for 700 million professionals.